Proteomics Intl Labs Ltd has released a press release.
September 2022 Quarterly Activities Report and Appendix 4C
Filed with ASX ·
6ix hasn’t read this filing yet.
Proteomics International Laboratories Ltd. on 6ix
Story so far
Earlier from Proteomics International Laboratories
- Precision diagnostics facility receives $2m funding boost
- Proteomics receives $1.7 million in R&D tax incentive
- New Oesophageal Cancer Diagnostic shows strong performance
- OxiDx launched to maximise oxidative stress technology
- Completion of Placement and Exercise of Performance Rights
Later from Proteomics International Laboratories
- PromarkerD patent granted in Hong Kong
- AGM Chairmans Address and Investor Presentation
- UK NICE publishes Medtech Innovation Briefing on PromarkerD
- CPT PLA reimbursement code approved in US for PromarkerD
- Letter of intent with Sonic Healthcare USA extended
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories